Morepen Labs share price: Volumes on the Morepen Labs counter jumped suddenly around 1:05 PM with around 1.67 million shares changing hands in multiple tranches on the BSE

Morepen Laboratories Ltd. has lost -42.24% in the last 6 Months

Morepen Laboratories Ltd.

14 Dec 2024

49.38

3.22%

Dr Morepen Eyes Rs 500-Crore Revenue From Wellness Business In Four Years

NDTV Profit

Dr Morepen has entered into the wellness segment with the launch of a new weight management programme aimed at addressing the issue of obesity.

Morepen Laboratories Ltd. is trading below its 50 day SMA of 54.2

Morepen Laboratories Ltd.

11 Dec 2024

49.38

3.22%

Dr Morepen launches weight management product, forays into wellness biz

Business Standard

Company eyes Rs 30 crore revenue in first year, Rs 200 crore by 2030

Morepen Laboratories Ltd. is trading below its 50 day SMA of 54.2

Dr. Morepen eyes Rs 100 crore revenue in next three years from this weight loss product

Business Today | 10 Dec 2024 1 more

Morepen Laboratories Ltd.

10 Dec 2024

49.38

3.22%

Dr Morepen forays into wellness segment with weight management initiative

Business Standard

Dr Morepen on Tuesday forayed into the growing wellness segment with the launch of a weight management initiative. The company, a fully-owned subsidiary of Morepen Laboratories, is looking to establish itself in the segment which is currently valued at around Rs 12,000 crore and growing at an annual rate of 16 per cent. The company has launched its wellness product -- LightLife -- designed to tackle India's growing obesity crisis. India's obesity rate is increasing and this segment is expected to touch USD 52.3 billion by 2032, "reflecting the urgency to address weight management with solutions that are both safe and effective," Dr Morepen CEO Varun Suri said. With LightLife the company is looking to address the obesity issue without crash diets or harmful fads, he stated. According to the World Obesity Atlas 2024, over 25 per cent of Indian adults are projected to face obesity by 2035. Suri said the company's initiative is about promoting a healthy balanced lifestyle through...

Morepen Laboratories Ltd. is trading below its 50 day SMA of 54.2

Morepen Laboratories Ltd.

11 Nov 2024

49.38

3.22%

to see Rapid results content

Morepen Laboratories Ltd.

07 Oct 2024

49.38

3.22%

Glucometer maker Morepen Labs to hive off medical devices business

Business Standard

Expanding capacities, backward integrating production and eyeing US market for exports

Morepen Laboratories Ltd.'s price crossed above 30Day SMA today

Morepen Laboratories Ltd.

04 Sep 2024

49.38

3.22%

Morepen Lab rallies 8% in weak market; zooms 63% over QIP price in 1 month

Business Standard

The stock hit a multi-year high of Rs 88.85 was trading 63 per cent higher against its qualified institutional placement (QIP) price of Rs 54.37 per share.